Emisphere settles dispute with Lilly
-
- September
- 25
Emisphere Technologies Inc. has agreed to accept $18 million from Eli Lilly and Co. to settle the pending litigation between the two companies, the Tarrytown-based biotech company said today. This settles a dispute over Emisphere’s GLP molecule technology, an osteoporosis drug. A U.S. district court judge ruled in January that Lilly improperly broke an agreement with Emisphere, clearing the way for the Emisphere to license technology for the osteoporosis drug to a new partner. In April, an appeals court judge upheld that ruling.
This entry was posted
on Tuesday, September 25th, 2007 at 5:12 pm by Julie Moran Alterio.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: 
| 
Print
| 
Email
